Cargando…
The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular char...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623978/ https://www.ncbi.nlm.nih.gov/pubmed/36319958 http://dx.doi.org/10.1186/s12883-022-02905-w |
_version_ | 1784822128290299904 |
---|---|
author | Wang, Ning Han, Xu Hao, Shengpu Han, Jingzhe Zhou, Xiaomeng Sun, Shuyan Tang, Jin Lu, Yanpeng Wu, Hongran Ma, Shaojuan Song, Xueqin Ji, Guang |
author_facet | Wang, Ning Han, Xu Hao, Shengpu Han, Jingzhe Zhou, Xiaomeng Sun, Shuyan Tang, Jin Lu, Yanpeng Wu, Hongran Ma, Shaojuan Song, Xueqin Ji, Guang |
author_sort | Wang, Ning |
collection | PubMed |
description | BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular characteristics of 26 Chinese patients with dysferlinopathy screened by immunohistochemistry staining and pathogenic variants in DYSF genes. RESULTS: Among 26 patients with dysferlinopathy, 18 patients (69.2%) presented as Limb-girdle Muscular Dystrophy Type R2 (LGMD R2), 4 (15.4%) had a phenotype of Miyoshi myopathy (MM), and 4 (15.4%) presented as asymptomatic hyperCKemia. Fifteen patients (57.7%) were originally misdiagnosed as inflammatory myopathy or other diseases. Fifteen novel variants were identified among the 40 variant sites identified in this cohort. CONCLUSION: Dysferlinopathy is a clinically and genetically heterogeneous group of disorders with various phenotypes, a high proportion of novel variants, and a high rate of misdiagnosis before immunohistochemistry staining and genetic analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-02905-w. |
format | Online Article Text |
id | pubmed-9623978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96239782022-11-02 The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants Wang, Ning Han, Xu Hao, Shengpu Han, Jingzhe Zhou, Xiaomeng Sun, Shuyan Tang, Jin Lu, Yanpeng Wu, Hongran Ma, Shaojuan Song, Xueqin Ji, Guang BMC Neurol Research BACKGROUND: Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. METHODS: We reviewed the clinical and pathological data as well as the molecular characteristics of 26 Chinese patients with dysferlinopathy screened by immunohistochemistry staining and pathogenic variants in DYSF genes. RESULTS: Among 26 patients with dysferlinopathy, 18 patients (69.2%) presented as Limb-girdle Muscular Dystrophy Type R2 (LGMD R2), 4 (15.4%) had a phenotype of Miyoshi myopathy (MM), and 4 (15.4%) presented as asymptomatic hyperCKemia. Fifteen patients (57.7%) were originally misdiagnosed as inflammatory myopathy or other diseases. Fifteen novel variants were identified among the 40 variant sites identified in this cohort. CONCLUSION: Dysferlinopathy is a clinically and genetically heterogeneous group of disorders with various phenotypes, a high proportion of novel variants, and a high rate of misdiagnosis before immunohistochemistry staining and genetic analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-022-02905-w. BioMed Central 2022-11-01 /pmc/articles/PMC9623978/ /pubmed/36319958 http://dx.doi.org/10.1186/s12883-022-02905-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Ning Han, Xu Hao, Shengpu Han, Jingzhe Zhou, Xiaomeng Sun, Shuyan Tang, Jin Lu, Yanpeng Wu, Hongran Ma, Shaojuan Song, Xueqin Ji, Guang The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title | The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title_full | The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title_fullStr | The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title_full_unstemmed | The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title_short | The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
title_sort | clinical, myopathological, and molecular characteristics of 26 chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623978/ https://www.ncbi.nlm.nih.gov/pubmed/36319958 http://dx.doi.org/10.1186/s12883-022-02905-w |
work_keys_str_mv | AT wangning theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT hanxu theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT haoshengpu theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT hanjingzhe theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT zhouxiaomeng theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT sunshuyan theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT tangjin theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT luyanpeng theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT wuhongran theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT mashaojuan theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT songxueqin theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT jiguang theclinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT wangning clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT hanxu clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT haoshengpu clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT hanjingzhe clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT zhouxiaomeng clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT sunshuyan clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT tangjin clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT luyanpeng clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT wuhongran clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT mashaojuan clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT songxueqin clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants AT jiguang clinicalmyopathologicalandmolecularcharacteristicsof26chinesepatientswithdysferlinopathyahighproportionofmisdiagnosisandnovelvariants |